[Two Cases of Esophageal Neuroendocrine Carcinoma That Were Successfully Controlled by Multi-Modality Therapy].
Gan To Kagaku Ryoho
; 48(13): 1856-1858, 2021 Dec.
Article
en Ja
| MEDLINE
| ID: mdl-35045427
ABSTRACT
Esophageal neuroendocrine carcinoma is extremely rare, and its treatment strategy has not been established. We report 2 cases esophageal neuroendocrine carcinoma. Case 1 A 74-year-old man was diagnosed as having esophageal neuroendocrine carcinoma(clinical T3N4M0, Stage â
£a). He received 60 Gy of radiation therapy with etoposide(100 mg/m2)plus cisplatin(80 mg/m2). No recurrence has been detected 1 year after treatment. Case 2 A 78-year-old man was diagnosed as esophageal neuroendocrine carcinoma(clinical T3N0M0, Stage â
¡). He underwent esophagectomy with 3 field lymph nodes dissection. Adjuvant chemotherapy was administered with irinotecan(60 mg/m2)plus cisplatin(60 mg/m2). After chemotherapy, he survived 1 year without recurrence.
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Esofágicas
/
Carcinoma Neuroendocrino
Idioma:
Ja
Revista:
Gan To Kagaku Ryoho
Año:
2021
Tipo del documento:
Article